2011 ASH Program Book - American Society of Hypertension

More documents

Recommendations

Info

Faculty Disclosure Listing continued Angela L. Brown, MD Advisor/Consultant: Takeda. Speakers’ Bureau/Speaking/Teaching: Novartis, Forest, Pfizer. Nancy J. Brown, MD Advisor/Consultant: Novartis, Merck. Grant/Research Support: Forest, Shire HGT. Ownership/Partnership or Principal of Non-Profit or for Profit Corporation: Protein Discovery. David A. Bushinksy, MD Employment Income/Salary: Univeristy of Rochester. Advisor/Consultant: Amgen, Genzyme, Relypsa, Cytochroma. Grant/Research Support: National Institutes of Health, Renal Research Institute. Ownership Interest (Stocks, Excluding Diversified Mutual Funds): Amgen, Relypsa. Speakers’ Bureau/Speaking/Teaching: Amgen, Genzyme. Norman R.C. Campbell, MD Other Relevant Financial Benefit or Relationship: Boehringer-Ingelheim. Oscar A. Carretero, MD Grant/Research Support: National Institutes of Health, Roche Pharmaceuticals. Barry L. Carter, PharmD I have no relationships to disclose. Alessandro Cataliotti, MD, PhD Grant/Research Support: National Institutes of Health. John R. Cockcroft, MD Advisor/Consultant: Forest, Novartis, Genzyme, GlaxoSmithKline. Grant/Research Support: GlaxoSmithKline. Speakers’ Bureau/Speaking/Teaching: Genzyme, Amgen. Jay N. Cohn, MD I have no relationships to disclose. Steven D. Crowley, PhD I have no relationships to disclose. William C. Cushman, MD Advisor/Consultant: Takeda, Novartis. Stephen R. Daniels, MD, PhD I have no relationships to disclose. Michael H. Davidson, MD Advisor/Consultant: Abbott, Aegerion, Amgen, AstraZeneca, Atherotech, Daiichi-Sankyo, DTC MD, Esperion, GlaxoSmithKline, iMD (Intelligent Medical Decisions), Kinemed, LipoScience, Merck, Novo Nordisk, Roche, Sanofi-Aventis, Synarc, Takeda, Vindico Medical Education. Trustee/Board Member/Committee Member: DTC MD, Omthera, Professional Education, Inc. Medical Education Company, Sonogene. Grant/Research Support: Abbott, Daiichi-Sankyo, GlaxoSmithKline, Merck, Roche. Daniel Duprez, MD, PhD Advisor/Consultant: Novartis, Abbott, Pfizer, Merck. Grant/Research Support: Novartis, Roche, Merck. Speakers’ Bureau/Speaking/Teaching: Novartis, Pfizer, Merck, Boehringer-Ingelheim, Forest, Abbott. Lance D. Dworkin, MD Advisor/Consultant: Questcor. Grant/Research Support: Questcor, Pfizer, AstraZeneca. 146
Faculty Disclosure Listing continued Brent M. Egan, MD Advisor/Consultant: NiCox. Grant/Research Support: Daiichi-Sankyo, Novartis, Takeda. Paula T. Einhorn, MD, MS I have no relationships to disclose. William J. Elliott, MD, PhD Royalties (Including Trademarks or Patents): Elsevier, Inc. Grant/ Research Support: Forest Research Institute. Speakers’ Bureau/Speaking/Teaching: Forest Laboratories, Boehringer-Ingelheim, NiCox, Inc., American Society of Hypertension. Murray Epstein, MD Advisor/Consultant: Bristol-Myers Squibb, AstraZeneca. Murray D. Esler, MBBS, PhD Advisor/Consultant: ADRIAN Corporation, Chief Investigator International Trial. Speakers’ Bureau/Speaking/Teaching: Solvay Australia. Bonita Falkner, MD Advisor/Consultant: AstraZeneca, Pfizer, Merck. Sadaf Farooqi, PhD I have no relationships to disclose. Daniel I. Feig, MD, PhD I have no relationships to disclose. Ross Feldman, MD Advisor/Consultant: AstraZeneca, Boehringer-Ingelheim, Bristol- Myers Squibb, Merck, Forest Canada, Novartis, Pfizer, Sanofi-Aventis, Servier, Takeda. Trustee/Board Member/Committee Member: Servier, Takeda. Keith C. Ferdinand, MD Advisor/Consultant: AstraZeneca, Merck, Pfizer, Novartis, Takeda, Forest. Grant/Research Support: Daiichi-Sankyo. Speakers’ Bureau/ Speaking/Teaching: Novartis, AstraZeneca. Member, ASH Board of Directors. John M. Flack, MD, MPH Advisor/Consultant: Novartis, Daiichi-Sankyo. Grant Research/ Support: Novartis. Speakers’ Bureau/Speaking/Teaching: Novartis, Daiichi-Sankyo, Boehringer-Ingelheim. Joseph T. Flynn, MD Advisor/Consultant: Pfizer, Novartis, PTC Therapeutics. Stanley S. Franklin, MD I have no relationships to disclose. William H. Frishman, MD Ownership Interest (Stocks, Excluding Diversified Mutual Funds): Merck, Pfizer. Speakers’ Bureau/Speaking/Teaching: NCME (Bristol- Myers Squibb), Pfizer, Forest Laboratories, Boehringer-Ingelheim. James B. Froehlich, MD, MPH Advisor/Consultant: Merck, Sanofi-Aventis. Speakers’ Bureau/Speaking/Teaching: Merck, Schering-Plough. Leonard M. Fromer, MD Trustee/Board Member/Committee Member: TransferMed, LLC. Jeffrey L. Garvin, PhD Grant/Research Support: National Institutes of Health. 147
Page 1 and 2:
American Society of Hypertension, I
Page 3:
Visit booth #1100 to find out more
Page 6 and 7:
Past Presidents of the American Soc
Page 8 and 9:
Program Color Key The pages of this
Page 10 and 11:
Letter continued Following the Awar
Page 12 and 13:
General Information continued Discl
Page 14 and 15:
General Information continued ASH S
Page 16 and 17:
General Information continued ASH P
Page 18 and 19:
2011 ASH Corporate Members Boehring
Page 20 and 21:
ASH Leadership 2010-2011 Board of D
Page 22 and 23:
Special Lecture Monday, May 23, 201
Page 24 and 25:
Young Scholar Award* Monday, May 23
Page 26 and 27:
Special Lecture Monday, May 23, 201
Page 28 and 29:
2011 Abstract Reviewers Lawrence J.
Page 30 and 31:
More than half of hypertensive pati
Page 32 and 33:
Poster Category Presentation Poster
Page 34 and 35:
2011 ASH Faculty Rajiv Agarwal, MD
Page 36 and 37:
2011 ASH Faculty continued David L.
Page 38 and 39:
American Society of Hypertension, I
Page 40 and 41:
Program Color Key The pages of this
Page 42 and 43:
MAY 21 Saturday Morning Hypertensio
Page 44 and 45:
MAY 21 Sessions Saturday Afternoon
Page 46 and 47:
Page 48 and 49:
Page 50 and 51:
MAY 21 Posters Saturday Evening Pos
Page 52 and 53:
MAY 22 Sunday morning Sessions cont
Page 54 and 55:
MAY 22 Sessions Sunday Morning 9:00
Page 56 and 57:
MAY 22 Sessions Sunday Morning 9:00
Page 58 and 59:
MAY 22 Debates Sunday Morning 11:00
Page 60 and 61:
MAY 22 Plenary Session I Sunday Aft
Page 62 and 63:
MAY 22 Special Sessions Sunday Afte
Page 64 and 65:
MAY 22 Sessions Sunday Afternoon 3:
Page 66 and 67:
MAY 23 Satellite Symposium 6:00 AM
Page 68 and 69:
MAY 23 Sessions Monday morning 8:00
Page 70 and 71:
Page 72 and 73:
Page 74 and 75:
Page 76 and 77:
Page 78 and 79:
MAY 23 Plenary Session II Monday Af
Page 80 and 81:
MAY 24 Sessions Tuesday Morning 8:1
Page 82 and 83:
MAY 24 Sessions Tuesday Morning 10:
Page 84 and 85:
MAY 24 Sessions Tuesday Morning 10:
Page 87 and 88:
2011 American Society of Hypertensi
Page 89 and 90:
Saturday Afternoon MAY 21 Posters 4
Page 91 and 92:
Saturday Afternoon MAY 21 Posters P
Page 93 and 94:
Saturday Afternoon MAY 21 Posters E
Page 95 and 96:
Saturday Afternoon MAY 21 Posters P
Page 97 and 98: Saturday Afternoon MAY 21 Posters P
Page 99 and 100: Saturday Afternoon MAY 21 Posters I
Page 107 and 108: Sunday Morning MAY 22 Posters 10:00
Page 109 and 110: Sunday Morning MAY 22 Posters 10:00
Page 111 and 112: Sunday Morning MAY 22 Posters PO-13
Page 127 and 128: Monday Morning Afternoon MAY 21 23
Page 147: Faculty Disclosure Listing Rajiv Ag
Page 151 and 152: Faculty Disclosure Listing continue
Page 157 and 158: ASH Hypertension Resource Pavilion
Page 159 and 160: 2011 ASH Innovations Theater Rhinel
Page 161 and 162: 2011 ASH Exhibitors continued A & D
Page 163 and 164: 2011 ASH Exhibitors continued David
Page 165 and 166: 2011 ASH Exhibitors continued Inter
Page 167 and 168: 2011 ASH Exhibitors continued Novar
Page 169 and 170: 2011 ASH Exhibitors continued Wiley
Page 171 and 172: Author Index Berezina, Aelita V., 8
Page 173 and 174: Author Index Eguchi, Kazuo, 110, 13
Page 175 and 176: Author Index Ikeda, Yasuhiro, 116 I
Page 177 and 178: Author Index Makani, Harikrishna, 1
Page 179 and 180: Author Index Rabelink, Ton J., 93 R
Page 181 and 182: Author Index Tatsis, I., 92, 124 Ta
Page 183 and 184: Hilton New York Floor Plans Second
Page 185 and 186: Hilton New York Floor Plans Fourth
Page 187 and 188: Tekamlo (aliskiren and amlodipine)
Page 189 and 190: 25% (systolic) and 27% (diastolic)
Page 191 and 192: Two cases of angioedema with respir
Page 193 and 194: amlodipine and sildenafil were used
Page 195 and 196: Amlodipine besylate Single oral dos
show all

2011 ASH Program Book - American Society of Hypertension

Create successful ePaper yourself

Delete template?

Save as template?